Back to FAYEZ SAROFIM & CO

ABT
Showing 8 of 30 quarters

Position history for FAYEZ SAROFIM & CO's holdings in ABBOTT LABORATORIES

FAYEZ SAROFIM & CO holds 4.3M shares of ABT (ABBOTT LABORATORIES), worth $439.6M as of 2026-Q1. The position was decreased (-4.4% shares). ABT represents 1.1% of FAYEZ SAROFIM & CO's portfolio.

Current Value

$439.6M

Current Shares

4.3M

Total Value Change

+$10.4M

Total Shares Change

+151,416

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
4.3M
-4.4%
$439.6M1.1%$113.61
0
2025-Q4
Decreased
4.5M
-0.8%
$561.4M1.3%$125.15
0
2025-Q3
Decreased
4.5M
-0.1%
$609.2M1.4%$131.85
0
2025-Q2
Decreased
4.5M
-2.1%
$619.1M1.5%$132.52
0
2025-Q1
Decreased
4.6M
-1.2%
$617.7M1.5%$128.41
0
2024-Q4
Increased
4.7M
+11.6%
$532.9M1.3%$110.14
55
2024-Q3
Increased
4.2M
+1.4%
$477.7M1.2%$109.27
50
2024-Q2
Increased
4.1M
+2.5%
$429.2M1.2%$100.45
50

Other major holders of ABT: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used